SCHEMBL7664873

SCHEMBL7664873

CCOC(=O)c1ccccc1C=Cc1ccncc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.54
HSD17B10 Q99714 2/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPK1 P28482 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
SNCA P37840 2/20 0.44
CTDSP1 Q9GZU7 1/20 0.44
TP53 P04637 1/20 0.43
BACE1 P56817 1/20 0.43
CASP1 P29466 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
SRC P12931 1/20 0.42
HTT P42858 1/20 0.42
LMNA P02545 1/20 0.42
TBXAS1 P24557 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7790064 0.88 TSHR (0.61) TSHRHSD17B10ALDH1A1CTDSP1BACE1
SCHEMBL27533745 0.88 TSHR (0.61) TSHRHSD17B10ALDH1A1CTDSP1BACE1
SCHEMBL27555177 0.84 BACE1 (0.56) TSHRHSD17B10ALDH1A1SNCABACE1
Dimethylamine SCHEMBL1335350 0.82 TSHR (0.53) TSHRHSD17B10ALDH1A1CTDSP1BACE1
SCHEMBL9000587 0.81 TSHR (0.59) TSHRHSD17B10ALDH1A1MAPK1TP53
SCHEMBL9000589 0.81 TSHR (0.59) TSHRHSD17B10ALDH1A1MAPK1TP53
SCHEMBL2771156 0.81 TSHR (0.62) TSHRHSD17B10ALDH1A1MAPK1HTT
SCHEMBL1335348 0.79 CAPN1 (0.54) TSHRHSD17B10ALDH1A1CTDSP1BACE1
SCHEMBL1335346 0.79 CAPN1 (0.54) TSHRHSD17B10ALDH1A1CTDSP1BACE1
SCHEMBL6386138 0.78 TSHR (0.47) TSHRHSD17B10ALDH1A1MAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed